Taken together, genetic evidence reveals that downregulation of CISD2 accelerates liver aging and promotes the development of age-related liver diseases, including NAFLD, NASH, and HCC. The gene discussed is CISD2; the disease is metabolic dysfunction-associated steatohepatitis.